WeVote
Log In

Bill

Bill

A 6056

Implements Blue Band Program to address preeclampsia in New Jersey.

2024-2025 Regular Session Introduced by Shanique Speight

New Jersey's Blue Band Program creates a coordinated preeclampsia intervention initiative to reduce maternal health complications during pregnancy.

Introduced in the Assembly, Referred to Assembly Health Committee
#humansvcs
0
WeVote Research Nonpartisan
Bill Summary · A 6056

Legislative bill overview

Bill A 6056 establishes the Blue Band Program in New Jersey specifically designed to address preeclampsia, a serious pregnancy-related condition characterized by high blood pressure that can threaten both mother and fetus. The program appears to create a coordinated initiative, though specific mechanisms and funding details would require review of the full bill text.

Why is this important

Preeclampsia affects 3-5% of pregnancies and remains a leading cause of maternal mortality and morbidity in the United States. New Jersey's maternal mortality rate exceeds the national average, making targeted interventions particularly relevant for the state's maternal health outcomes.

Potential points of contention

  • Funding mechanisms and costs: Whether the program is fully funded, partially funded, or relies on redirected resources from existing health initiatives
  • Implementation timeline and capacity: Whether healthcare providers and facilities have adequate training and infrastructure to execute the program effectively
  • Scope and accessibility: Whether the program reaches all pregnant individuals across socioeconomic and geographic lines, or if certain populations may have limited access

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.